The I-direct healthcare universe is expected to register 10.8% YoY revenue growth to | 44082 crore on the back of acquisitions and a recovery of the US base business besides currency tailwinds. However, on a case by case basis, growth numbers may be varied as the quarter is likely to see a positive rub-off for some players and at the same time structural limiting factors for others. Domestic growth can be muted for some companies on the back of a weaker acute season impact. This is also likely to impact their EBITDA margins. US revenues (select pack) are expected to grow 12.5%...